+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID05721170

Evaluating Beta-blocker Continuation Versus Temporary Interruption in Patients Undergoing Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis

Led by National and Kapodistrian University of Athens · Updated on 2026-10-20

348

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety of continuing versus temporarily stopping chronic beta-blocker therapy in patients undergoing transcatheter aortic valve implantation TAVI for severe symptomatic aortic stenosis. This prospective, multicenter, randomized trial compares two strategies to understand their impact on conduction disturbances and the need for permanent pacemakers after TAVI. The study addresses an important clinical question as beta-blockers may affect heart rhythm during this procedure, and current evidence is inconclusive. Participants are randomly assigned to either continue their prescribed beta-blocker medication starting at least 72 hours before TAVI through 7 days after the procedure, or to temporarily stop beta-blocker therapy during this period. Dose adjustments or early reinitiation of beta-blockers are allowed if medically necessary. All TAVI procedures follow standard care, and decisions about pacemaker implantation are made independently of treatment assignment. During the study, participants will be monitored with clinical and electrocardiographic assessments at baseline, during hospitalization, at discharge, and at 7 days, 30 days, and 12 months after TAVI. Researchers will measure the rate of new permanent pacemaker implantation within 7 days as the primary outcome and will also track heart rhythm disturbances, arrhythmias, hemodynamic changes, mortality, and treatment adherence. Follow-up continues up to one year to evaluate longer-term effects and safety.

CONDITIONS

Brief Title

Impact of Beta Blockers on TAVI (BETA-TAVI)

Research Team

L

Leonidas Koliastasis, MD, MSc, PhD

O

Odysseas Katsaros, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here